Uitgebreid zoeken

Leonard S. Schleifer is medeoprichter van Regeneron Pharmaceuticals, Inc. en is co-voorzitter, Chief Executive Officer & directeur bij dit bedrijf. Daarvoor was hij assistent professor aan het Weill Cornell Medical College. Dr. Schleifer behaalde een doctoraat aan de Universiteit van Virginia.

Arthur Schleifer worked as Director of New Business Development at Caesars License Co. LLC, Chief Marketing Officer at Pinnacle Entertainment, Inc., and Chief Marketing Officer at Groundfloor Finance, Inc. He holds a Master's in Business Administration from Harvard University and an undergraduate degree from Tufts University.

Mr. Norman Schleifer is Chief Operating & Financial Officer at Iguana Healthcare Management LLC.
He has extensive experience in hedge fund administration and financial management, and most recently served as the Chief Financial Officer and Chief Operating Officer of Sivik Global Healthcare, LLC, a global healthcare long/short equity hedge fund.
Prior to Sivik, he served in a similar capacity at Merlin Biomed Group, LLC, a healthcare long/ short equity hedge fund and private equity fund managed by Stuart Weisbrod.
From 1993 to 1999, Mr. Schleifer was the Chief Financial Officer for Oracle Partners, LP, a global healthcare long/short equity hedge fund.
In addition, he spent 9 years as Controller/Assistant Trader at Morgens, Waterfall, Vintiadis & Co, a New York-based long/short hedge fund.
Norman began his career at Harry Goodkin & Co, CPAs, where he served as the Senior Audit Manager for hedge funds.
Mr. Schleifer received his BS in Business Administration from Pace University.